Related by context. All words. (Click for frequent words.) 80 Immune Responses 77 Kinase Inhibitor 76 Endothelial Cells 76 Oral Fingolimod 76 Intracellular 76 Preclinical Study 76 Phospholipase A2 76 Signaling Pathways 76 Skeletal Muscle 76 Systemic Delivery 76 Inhibits 75 Mouse Models 75 Mouse Model 75 Preclinical Data 75 Modulates 75 Proteasome 75 Epithelial 75 Anti Tumor 75 Prolongs Survival 75 Dendritic Cell 75 Respiratory Virus 75 Protein Interactions 75 Clinical Outcome 75 Recombinant Human 75 RNAi Therapeutic 74 Therapeutic Potential 74 Chemokine Receptor 74 Progenitor Cells 74 Antitumor Activity 74 Pooled Analysis 74 Drug Candidate 74 Attenuates 74 Clinical Trial Results 74 Novel Mechanism 74 Inflammatory Arthritis 74 Virus Infection 74 Tyrosine Kinase Inhibitor 74 Antigen Specific 74 Antitumor 74 Anti Tumor Activity 74 Insulin Resistance 74 Inactivation 74 Adjuvant Chemotherapy 74 Phase 2b Trial 74 Protein Kinase 74 Androgen Receptor 73 Signaling Pathway 73 Relapsing Multiple Sclerosis 73 Cell Adhesion 73 Genetic Variation 73 Macrophage 73 Neuroprotection 73 Tumor Suppressor 73 Protein Expression 73 Diabetic Nephropathy 73 Immunomodulatory 73 Immune Cell 73 Parathyroid Hormone 73 Anticancer Activity 73 Gene Mutation 73 Epidermal Growth Factor Receptor 73 Gene Variants 73 Endothelial 73 Smooth Muscle 73 Viral Infections 73 Metastatic Melanoma 73 Inflammatory Markers 73 Novel Oral 73 Allogeneic 73 Glucocorticoid 73 Chronic Hepatitis C 73 Antiviral Activity 73 Improves Survival 73 Phase 2b Clinical Trial 73 Therapeutic Targets 73 Cancer Cells 73 Antisense Drug 73 Cannabinoid 73 Hematopoietic 73 Tumor Necrosis Factor 73 Polymorphism 72 Fungal Infections 72 Estrogen Receptor 72 Factor Receptor 72 Treating Chronic 72 Meets Primary Endpoint 72 Presents Preclinical Data 72 Aurora Kinase 72 Kinase Inhibitors 72 Nicotine Vaccine 72 Tumor Growth 72 Transcription Factor 72 Epstein Barr Virus EBV 72 Well Tolerated 72 Leukemias 72 Cytotoxicity 72 Somatostatin 72 Monoclonal Antibody 72 Renal Cell Carcinoma 72 Oxidative Stress 72 Oncogenic 72 Thyroid Hormone 72 Cytotoxic T 72 Urinary Incontinence 72 Phase 2a Clinical Trial 72 Mimetics 72 Orally Active 72 Gene Silencing 72 Cytochrome P# 72 Monoclonal 72 Therapeutic Vaccines 72 Subunit 72 Diabetic Neuropathy 72 Severe Sepsis 72 Angiogenic 72 Beneficial Effects 72 Demonstrates Efficacy 72 Meta Analysis 72 Novel Therapeutic 72 Novel Antibiotic 72 Present Preclinical Data 72 Monocytes 72 Novel Inhibitor 72 Antiviral Therapy 72 Selective Inhibitor 72 Leukemia Cells 72 Breast Cancer Metastasis 71 Fibrinogen 71 Drug Resistant 71 Immunogenicity 71 Cancer Stem Cells 71 Small Molecule 71 Phosphorylation 71 Shows Promising 71 Cell Proliferation 71 Hepatitis C Infection 71 Gastric Cancer 71 Pharmacokinetic Study 71 Brain Metastases 71 Unfractionated Heparin 71 Respiratory Syncytial Virus 71 Antigens 71 Neural Stem Cells 71 Hepatitis C Virus 71 Oligonucleotides 71 Radiation Induced 71 Circulating Tumor Cells 71 See CLINICAL PHARMACOLOGY 71 Inflammatory Diseases 71 Peripheral Blood 71 Late Breaker 71 Immunostimulatory 71 Transdermal Delivery 71 J Clin 71 Tumor Cells 71 Hepatitis B Virus 71 Inhibitory 71 Knee Osteoarthritis 71 Liver Injury 71 DNA Methylation 71 Cancer Vaccines 71 Synthetic Peptide 71 Lymphocytic 71 Patients Receiving 71 Mutational 71 Protein Synthesis 71 RNA Interference 71 Metastatic Renal Cell Carcinoma 71 Epithelium 71 Tumor Targeting 71 Shows Promise Against 71 Critically Ill Patients 71 Pharmacodynamics 71 Aliskiren 71 CYP#A# CYP#D# 71 Phase 2b Study 71 Beta Amyloid 71 Infected Patients 71 Previously Treated 71 Induces 71 Myelodysplastic Syndromes 71 Antiviral Drugs 71 Kidney Function 71 Chronic Myeloid Leukemia 71 Breast Cancer Cells 71 Receptor Agonist 71 Tubulin 71 Adenoviral 71 Anticancer Drugs 71 Hepatocellular Carcinoma 71 Transgenic Mice 71 TNF Blockers 71 Salivary 71 Hypertensive Patients 70 Adjuvant Therapy 70 Receptor Antagonists 70 Thrombotic 70 Dehydrogenase 70 Breast Cancer Recurrence 70 Septic Shock 70 Lymphoid 70 Nat Clin Pract 70 JAK Inhibitor 70 Immune Cells 70 Malignant Glioma 70 Tezampanel 70 Therapeutic Effects 70 Tumor Suppressor Gene 70 Liposomal 70 Combination Therapy 70 Targeted Therapy 70 Reductase 70 Complicated Skin 70 Mucosal 70 Vitro Activity 70 Prognostic Factors 70 Universal Flu Vaccine 70 Antiangiogenic 70 Immunotherapeutic 70 Ischemic 70 Therapeutic Antibody 70 Successfully Treated 70 Potent Anti 70 Malignant Melanoma 70 Prostatic 70 Study Evaluating 70 Conjugated 70 Vaccine Adjuvants 70 Autoantibodies 70 Improve Survival 70 Gene Variation 70 Molecular Mechanism 70 Fracture Risk 70 Recombinant Protein 70 Pulmonary Arterial Hypertension 70 Placebo Controlled Trial 70 Hormone Receptor Positive 70 Molecular Diagnostic 70 Histone 70 Secondary Hyperparathyroidism 70 Randomized Phase 70 Rotavirus Vaccine 70 Adjuvant Treatment 70 Oligonucleotide 70 Chronic Hepatitis B 70 Advanced Melanoma 70 Preclinical Models 70 Postmenopausal Women 70 Extracellular Matrix 70 Hormone Refractory Prostate Cancer 70 Pharmacokinetics PK 70 Targeted Therapies 70 Tumor Angiogenesis 70 Prognostic Value 70 Interferon Beta 70 Platelet Derived Growth 70 Anthrax Toxin 70 Immune Mediated 70 Analogs 70 Dose Response 70 Preclinical Evaluation 70 Ion Channels 70 Minimally Invasive Treatment 70 Myeloma Patients 70 Therapeutic Vaccine 70 Advanced Renal Cell 70 Antisense Oligonucleotides 70 Autoimmune Disease 70 Clinical Efficacy 70 Chemotherapeutic Agents 70 Genotypes 70 Disease Progression 70 RNAi Therapeutics 70 Patients Treated With 70 Retrovirus 70 Adenoma 70 Phase IIb Clinical Trial 70 Hypercholesterolemia 70 Am J Clin 70 Controlled Trial 70 Autoimmune Diseases 70 Dose Escalation 70 Vaccine Adjuvant 69 Transcriptional 69 Nucleoside 69 Uric Acid 69 TNF Alpha 69 Treatment Reduces 69 Diabetic Patients 69 Humanized Anti 69 Cell Differentiation 69 Cerebrospinal Fluid 69 Impairs 69 Phase IIb Trial 69 Homeostasis 69 Receptor Antagonist 69 Double Blind Placebo 69 Nicotinic 69 Sapacitabine 69 J Allergy Clin 69 Breast Tumors 69 Rheumatoid Arthritis Patients 69 Diabetic Foot Ulcer 69 Retroviral 69 Initiate Clinical Trial 69 Histone Deacetylase 69 Breast Cancers 69 Prognostic Significance 69 Genetic Variant 69 Investigational Compound 69 Polymerase Inhibitor 69 Combination Treatment 69 Novel Vaccine 69 Cardiotoxicity 69 Metabolic Disease 69 Plasmid DNA 69 II Clinical Trial 69 Coronary Arteries 69 Cytotoxic 69 Autoimmunity 69 Anticancer Drug 69 Hematopoietic Stem Cells 69 Appears Safe 69 Survival Benefit 69 Gene Variant 69 Malignancies 69 Effectively Treats 69 Insulin Sensitivity 69 Fibroblast 69 Apoptotic 69 Streptococcus agalactiae 69 Pegylated 69 Inflammatory Disease 69 Prophylactic Treatment 69 Long Term Efficacy 69 Hsp# Inhibitor 69 Inhaled Corticosteroids 69 Slow Progression 69 Experimental Vaccine 69 Nanoemulsion 69 Protein Involved 69 Transdermal Patch 69 Molecular Basis 69 Randomized Double blind 69 Anti CD# Antibody 69 protein tyrosine phosphatase 1B 69 Neurogenesis 69 Dose Finding 69 Novel Protein 69 Treated Patients 69 Monoclonal Antibodies 69 Oral Cavity 69 Single Dose 69 Novel Method 69 Amniotic Fluid 69 Premature Aging 69 siRNA Delivery 69 Synthase 69 Investigational Drug 69 Immunomedics Announces 69 Antifungal 69 Transcriptome 69 Controlled Study 69 Dose Ranging Study 69 Intravascular 69 Curr Opin 69 Renal Function 69 Lung Injury 69 Antithrombin 69 Oncolytic 69 Phase 2a Trial 69 Subtypes 69 Cardiovascular Disease Risk 69 Myeloid 69 Conjugate 69 Motility 69 Bortezomib 69 Upregulation 69 Replacement Therapy 69 J Am Coll 69 Solid Tumors 69 Dengue Virus 69 Mammalian Cells 69 Initiate Phase 69 Iron Overload 69 First Patient Dosed 69 HER2 HER3 69 Potent Inhibitor 69 Relapsed Refractory 69 Ovarian Cancers 69 Seasonal Influenza Vaccine 69 Carcinomas 69 Aggressive Prostate Cancer 69 Vaccine Candidate 69 #:#-# [033] 69 Protease Inhibitor 69 Drug Prevents 69 FDA Approvals 69 Neoplasia 69 Is Well Tolerated 69 Bone Metastases 69 Neuroprotective Effects 69 Magnetic Nanoparticles 69 Statistically Significant 69 Interferon Gamma 69 Innate Immunity 69 Endovascular Treatment 69 HDAC Inhibitor 69 AnaSpec Introduces 69 Circadian Clock 69 Improves Outcomes 69 Bone Marrow Stem Cells 69 Neuronal 69 Gene Linked 68 Ultrasensitive 68 Genes Involved 68 Genetic Mutation 68 Innate Immune 68 Drug Shows Promise 68 Demonstrated Significant 68 Progenitor Cell 68 Phase III Clinical Trial 68 Genes Predict 68 Effective Treatments 68 Myocardial Ischemia 68 Increased Mortality 68 Diagnostic Tests 68 Beta Blocker 68 JAK2 Inhibitor 68 Secretase 68 Molecular Mechanisms 68 Fibroblast Growth Factor 68 Significantly Improved 68 Abdominal Fat 68 Immunosuppression 68 Therapeutic Efficacy 68 Novel Antibody 68 First Patient Treated 68 Autologous Stem Cell Transplantation 68 Taxane 68 Incretin 68 Influenza Virus 68 Tumor Response 68 Treatment Naïve 68 pDC 68 Synaptic Plasticity 68 Investigational Agent 68 Contrast Agent 68 Safinamide 68 Interferon gamma 68 hypoxia inducible factor 68 Autoimmune Disorders 68 Monocyte 68 Drug Combo 68 Radiofrequency Ablation 68 interleukin IL -# 68 Protein Biomarker 68 Genes Linked 68 Files IND 68 Contrast Agents 68 Naive Patients 68 Novel Therapies 68 Decitabine 68 Progressive Multifocal Leukoencephalopathy 68 hepatoma 68 Tumor Microenvironment 68 Immunoglobulin 68 Abstract Number 68 Lung Tumors 68 Peripheral Arterial 68 Preclinical Efficacy 68 Viral Load 68 Oral Abstract 68 Peginterferon Alfa 2a 68 Activator CK # 68 Polyneuropathy 68 Endothelin 68 Neurotoxicity 68 Tumor Cell 68 Neoadjuvant Chemotherapy 68 Anti Angiogenic 68 Metastases 68 Protein Kinase C 68 Low Dose 68 Predict Risk 68 Phosphatase 68 Phase 1b Clinical Trial 68 Refractory Hodgkin Lymphoma 68 Lipoprotein 68 Anticancer Agent 68 Thromboembolism 68 Soft Tissue Sarcoma 68 Elderly Patients 68 Polymorphisms 68 abacavir Ziagen 68 Lowers Risk 68 Transfection 68 Serious Infections 68 generation antisense inhibitor 68 Multiple Myeloma Patients 68 Proves Effective 68 Orthop Surg 68 Infectivity 68 Acute Ischemic Stroke 68 vascular endothelial 68 Safety Tolerability 68 Trodusquemine MSI 68 PEGylated Fab fragment 68 Chronic Lymphocytic Leukemia 68 Inflammatory Response 68 Tyrosine Kinase 68 Intravesical 68 Protein Interaction 68 Neurotransmitter 68 Conjugates 68 HCV Infection 68 Nuclear Receptors 68 Invasive Breast Cancer 68 Immunologic 68 Microtubule 68 Renal Cancer 68 Endocrinol 68 Alkaline Phosphatase 68 Iron Deficiency 68 Oral Formulation 68 Pediatr 68 Metastatic Prostate Cancer 68 Anti Angiogenesis 68 Colorectal Adenomas 68 Collaborators Present 68 Oral Presentation 68 IND Filing 68 Oncolytic Reovirus 68 Epratuzumab 68 Chronic Sinusitis 68 Anti Inflammatory Drug 68 Treatment Naive Patients 68 Insulin Glargine 68 Atopic Dermatitis 68 Double Blind Randomized 68 J Nutr 68 Differentially 68 Premature Infants 68 Chronic Myelogenous Leukemia 68 Antithrombotic 68 Completes Patient Enrollment 68 Cyclooxygenase 2 68 Int J Radiat Oncol 68 Viral Infection 68 Bacterial Infections 68 Severe Asthma 68 Thiazolidinediones 68 Plaque Psoriasis 68 Epitopes 67 Elevated Levels 67 Multicenter Randomized 67 Liver Tumors 67 Biologic Therapy 67 Mesenchymal Stem Cells 67 Investigational Treatment 67 cMET 67 Autologous 67 Neurodegenerative Disease 67 Epithelial Cell 67 Newly Diagnosed Multiple Myeloma 67 Regenerative Cells 67 Genetic Basis 67 Aptamer 67 Nucleic Acids 67 Nephrol 67 Secretory 67 Phase IIa Clinical Trial 67 Small Intestine 67 Sangamo BioSciences Announces 67 Pediatric Patients 67 X Chromosome 67 Quantitation 67 Arch Neurol 67 Kidney Transplant Recipients 67 Placebo Controlled Study 67 Epitope 67 Postmenopausal Osteoporosis 67 Pathol 67 Clinical Trial Data 67 Protein Linked 67 Prospective Randomized 67 Proliferative 67 ACE Inhibitors 67 Mol Cell 67 Treatment Regimen 67 Genetic Marker 67 Risk Stratification 67 Janus kinase 67 #:#-# [023] 67 Poster Presentations 67 Cardiac Function 67 ST Elevation Myocardial 67 IND Application 67 Tumor Progression 67 Develops Novel 67 Cognitive Impairment 67 Sipuleucel T 67 Cytokine 67 Monotherapy 67 Schizophrenia Treatment 67 selective inhibition 67 Induces Apoptosis 67 Human Monoclonal Antibodies 67 Kidney Transplant Patients 67 Sleep Disturbances 67 Topical Treatment 67 Lanthanum Carbonate 67 Mg Usa 67 Mutagenesis 67 Eur J 67 Recurrent Breast Cancer 67 Crit Rev 67 Prostate Cancer Progression 67 Glufosfamide 67 Advanced Colorectal Cancer 67 Chronic Renal Failure 67 Electroporation 67 Improved Survival 67 Int J Obes Relat 67 Cell Transplants 67 Genes Associated 67 Cutaneous T 67 von Willebrand Factor 67 Ovarian Cancer Patients 67 Hepatocytes 67 Blood Vessels 67 abstr 67 Electrical Stimulation 67 Disease Causing 67 Benign Prostatic Hyperplasia 67 Cognitive Function 67 Breast Ultrasound 67 Cervical Dysplasia 67 ptau 67 Potentially Fatal 67 Oral Mucositis 67 Superoxide 67 Neovascularization 67 Detect Cancer 67 Laryngeal Cancer 67 Environ Health Perspect 67 Combination REOLYSIN R 67 Efficacious 67 plasmid DNA encoding 67 Receptor Signaling 67 Differential Diagnosis 67 Neuroprotective 67 Researchers Identify 67 Randomized Controlled Trials 67 J Am Acad 67 Poster Presentation 67 Malaria Vaccine 67 Dermatol 67 Selective Cardiac Myosin 67 Allergic Rhinitis 67 Treatment Experienced 67 Fondaparinux 67 Chronic Pelvic Pain 67 Blood Cancers 67 Chemotherapy Induced 67 Lipid Levels 67 Amino Acid 67 J Am Soc 67 Novel Small Molecule 67 Patients Suffering 67 T Lymphocyte 67 Non Alcoholic Fatty 67 Epilepsy Drug 67 Demonstrates Potent 67 Sex Hormones 67 Brain Tumors 67 Hormone Receptor 67 Neovascular Age Related Macular 67 Intradermal 67 Demonstrates Statistically Significant 67 Oxidative 67 Endothelium 67 Unresectable 67 Novel Approach 67 Sustained Release 67 Systemic Sclerosis 67 Ischemic Stroke 67 Lung Cancer Patients 67 Receives Orphan Drug Designation 67 Bacterial Infection 67 Adjuvanted 67 Asthma Treatment 67 Cell Transplant 67 Cholesterol Lowering Drug 67 Adefovir 67 Treatment Shows Promise 67 Osteoporosis Treatment 67 Blood Flow 67 Preterm Delivery 67 Cancer Incidence Mortality 67 Morpholino 67 Blood Clotting 67 Cytoplasmic 67 Adjunctive Therapy 67 Successfully Completes Phase 67 Test Detects 67 Suppresses 67 Initiates Phase III 67 LPA1 67 Non Invasive Treatment 67 Proteases 67 Breast Tissue 67 Interferons 67 Glycoprotein 67 JAK2 V#F 67 Hepatic Encephalopathy 67 Advanced Prostate Cancer 67 Nasal Powder 67 Stent Thrombosis 67 soluble tumor necrosis 67 Microalbuminuria 67 downregulates 67 Muscle Wasting 67 Lupus Drug 67 5 Fluorouracil 67 Bone Morphogenetic Protein 67 Phase Ib Clinical Trial 67 Xenografts 67 Muscarinic 67 Clinically Significant 67 HCV Protease Inhibitor 67 Neurosurg 67 Initiates Clinical Trial 67 Pafuramidine 67 Cancer Res 67 Human Monoclonal Antibody 67 Chronic Inflammation 67 Cyclin Dependent 67 Inhaled Nitric Oxide 67 Demonstrates Positive 67 Lung Cancer Survival 67 Develop Novel 67 NMDA Receptor 67 Phenotypes 67 B Cell Lymphoma 67 Efficacy Trial 67 Bioavailability 67 Lipid Metabolism 67 Oral Session 67 CYT# potent vascular disrupting 67 Scientists Identify 67 Metabolites 67 Binding Protein 67 Atypical Hemolytic Uremic Syndrome 67 Pluripotent Stem Cells 67 C Reactive Protein 67 Glucose Metabolism 67 Phenotypic 67 Leukocyte 67 Int J 67 Cholinesterase Inhibitors 67 Osteoporosis Drugs 67 SARS Virus 67 Neurol 67 Cytokines 67 Demonstrates Significant 67 Prostate Cancer Vaccine 67 Myelofibrosis 67 Potent Antiviral Activity 66 Telaprevir VX 66 MGd 66 Thromb Haemost 66 Cancer Therapies 66 Chemoradiation 66 Secretion 66 Hepatitis B Vaccine 66 downstream effector 66 Antibiotic Resistant 66 NDA Submission 66 Fewer Side Effects 66 Liver Failure 66 Hedgehog Pathway 66 Left Ventricular 66 Enzastaurin 66 Localized Prostate Cancer 66 Statin Therapy 66 Technological Advances 66 Pathogenic 66 Cocaine Addiction 66 Vertebral Fractures 66 Intravenous Formulation 66 Bile Acid 66 Randomized Clinical Trial 66 Neoplasms 66 Sustained Efficacy 66 Pathogenesis 66 Randomized Double Blind Placebo 66 Image Guided 66 Hippocampal 66 Nilotinib 66 Antisense 66 Endometrial 66 Overactive Bladder 66 #:#-# [035] 66 Significantly Improves 66 Pancreatic 66 BiTE Antibody 66 PPARgamma 66 Hepatocyte 66 Combo Therapy 66 anionic backbone 66 Cognitive Deficits 66 HCV Genotype 66 Endoplasmic Reticulum 66 Bosutinib 66 Renal Cell Cancer 66 Lymphocyte 66 Mycophenolate Mofetil 66 Androgen 66 Levels Linked 66 Brain Function 66 Angiotensin II 66 Endothelial Function 66 Liver Toxicity 66 Gram Negative 66 Patients Undergoing 66 Vaccine Protects Against 66 immunostimulatory 66 Prostate Tumors 66 Excretion 66 small molecule activator 66 HLA DR4 66 Randomized Double Blind 66 Presents Positive 66 Gram Positive 66 Gene Mutations 66 Solid Tumor 66 Therapy Improves 66 phosphatidylinositol 3 66 Smallpox Vaccine 66 PKC# 66 Predict Breast Cancer 66 Hip Fractures 66 Inhibit 66 Shown Effective 66 Pivotal Phase III 66 HIF biology 66 Aortic Stenosis 66 Therapy Reduces 66 chemokine receptor 66 Biomarker Panel 66 Slows Progression 66 Soluble CD# 66 Catheter Associated 66 Ebola Vaccine 66 Viral Suppression 66 Valopicitabine 66 Nucleic Acid 66 adhesion molecule 66 Clinical Evaluation 66 #-# Full Text 66 Prolonged Survival 66 Patient Enrollment 66 Vascular Inflammation 66 Novel Treatments 66 Brain Wiring 66 Metastatic Cancer 66 Artery Disease 66 Fast Skeletal Troponin 66 Gout Drug 66 Shows Efficacy 66 Retinoic Acid 66 Cytomegalovirus CMV 66 Rap1 66 Prevalence Worldwide 66 Brain Plasticity 66 TNFalpha 66 Integrase 66 Renal Impairment 66 Hemodialysis Patients 66 doi #.#/fj.#-# 66 Antihypertensive 66 mediated inhibition 66 Neuroendocrine Tumors 66 plasmacytoid dendritic cells 66 Chronic Rhinosinusitis 66 Dual Antiplatelet Therapy 66 Nymox NX 66 Multicenter Trial 66 thyrotropin 66 Radiation Dose 66 Completes Enrollment 66 Genetic Mutations 66 Mg Uk 66 Novel Therapeutics 66 Bavituximab 66 Disease Modifying 66 Digestive Tract 66 myelofibrosis polycythemia vera 66 Spinal Fluid 66 EGFR HER2 66 Lung Cancer Drug 66 Subgroup Analysis 66 Antipsychotic 66 Hyperlipidemia 66 extracellular signal 66 Respiratory Syncytial Virus RSV 66 Bacterial Cell 66 Blinatumomab 66 5 HT6 receptor 66 Gastrointestinal Stromal Tumors 66 Reperfusion Injury 66 Immune Response 66 Fulvestrant 66 Neural Stem Cell 66 Clusterin 66 Hematological Malignancies 66 Menopausal Women 66 TNF Tumor Necrosis Factor 66 Malignancy 66 Antitumor activity 66 Squamous Cell Carcinoma 66 Anti Inflammatory 66 Resistant Hypertension 66 monocyte chemotactic protein 66 Metastatic Colorectal Cancer 66 Cancer Biomarkers 66 Postdoctoral Position 66 Free Full Text 66 Colorectal Cancer Patients 66 phosphorylated tau 66 Protease 66 Situ Hybridization 66 Pre Cancerous 66 Prostate Cancer Patients 66 Multidrug Resistant 66 Migraine Treatment 66 Tyrosine 66 Protease Inhibitors 66 Organ Rejection 66 #:#-# [037] 66 Melphalan 66 Primary Hypercholesterolemia 66 Mutation Analysis 66 Diabetic Kidney Disease 66 Germline 66 Cardiovascular Outcomes 66 Newly Diagnosed 66 Pathogen Detection 66 Pharmacologic 66 Brain Derived Neurotrophic 66 Adult Stem Cell Therapy 66 Breast Density 66 Avian Flu Vaccine 66 Plus Ribavirin 66 familial amyloidotic polyneuropathy FAP 66 Erectile Dysfunction Drug 66 Anthracycline 66 Relapsed Multiple Myeloma 66 selective modulator 66 Intracoronary 66 Cell Derived 66 Phase III Pivotal 66 Heart Failure Patients 66 Pharmacologic Treatment 66 Suicidality 66 LPS induced 66 Cell Lymphoma 66 Single Molecule 66 Skin Disorders 66 Diabetic Foot Ulcers 66 IgG1 66 Cognitive Decline 66 Nebulized 66 Herpes Virus 66 Initiates Clinical 66 Cancer Treatments 66 Anesth 66 Pharmacyclics Announces 66 Acute Heart Failure 66 Oncogene 66 Obstet Gynecol 66 Cancer Immunotherapy 66 Advanced Ovarian Cancer 66 Left Ventricular Hypertrophy 66 Prodrugs 66 Myelodysplastic Syndrome MDS 66 ORLive Presents 66 Pegylated Interferon 66 Hypoxia Inducible Factor 66 Transmembrane 66 Confirmatory Phase 66 Suppl. 66 Chronic Lymphocytic Leukemia CLL 66 Nerve Cell 66 Radiofrequency Ablation RFA 66 Peginterferon 66 Antiplatelet Therapy 66 Endometrial Cancer